CID 53481209

Ganglioside gq1c (d18:0/14:0)

Structural Information

Molecular Formula
C103H177N5O55
SMILES
CCCCCCCCCCCCCCC[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O[C@@]5(C[C@@H]([C@H](C(O5)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)CC(=O)C)O[C@@]6(C[C@@H]([C@H](C(O6)[C@@H]([C@@H](CO)O[C@@]7(C[C@@H]([C@H](C(O7)[C@@H]([C@@H](CO)O[C@@]8(C[C@@H]([C@H](C(O8)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)C(=O)O)O)O)O)NC(=O)CCCCCCCCCCCCC)O
InChI
InChI=1S/C103H177N5O55/c1-8-10-12-14-16-18-20-21-23-24-26-28-30-32-55(122)54(108-68(129)33-31-29-27-25-22-19-17-15-13-11-9-2)47-148-93-80(137)79(136)84(66(45-115)151-93)154-95-82(139)91(85(67(46-116)152-95)155-92-53(34-48(3)117)83(75(132)62(41-111)149-92)153-94-81(138)90(76(133)63(42-112)150-94)162-102(98(144)145)37-58(125)70(105-50(5)119)87(159-102)74(131)61(128)40-110)163-103(99(146)147)38-59(126)72(107-52(7)121)89(161-103)78(135)65(44-114)157-101(97(142)143)36-57(124)71(106-51(6)120)88(160-101)77(134)64(43-113)156-100(96(140)141)35-56(123)69(104-49(4)118)86(158-100)73(130)60(127)39-109/h53-67,69-95,109-116,122-128,130-139H,8-47H2,1-7H3,(H,104,118)(H,105,119)(H,106,120)(H,107,121)(H,108,129)(H,140,141)(H,142,143)(H,144,145)(H,146,147)/t53-,54+,55-,56+,57+,58+,59+,60-,61-,62-,63-,64-,65-,66-,67-,69-,70-,71-,72-,73-,74-,75+,76+,77-,78-,79-,80-,81-,82-,83-,84-,85+,86?,87?,88?,89?,90+,91-,92+,93-,94+,95+,100-,101-,102+,103+/m1/s1
InChIKey
BIHZHBDPQQPHIM-ONQYWAELSA-N
Compound name
(2S,4S,5R)-5-acetamido-2-[(2R,3R,4S,5S,6R)-2-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5R,6S)-4-[(2S,4S,5R)-5-acetamido-6-[(1S,2R)-2-[(2S,4S,5R)-5-acetamido-6-[(1S,2R)-2-[(2S,4S,5R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-2-carboxy-4-hydroxyoxan-2-yl]oxy-1,3-dihydroxypropyl]-2-carboxy-4-hydroxyoxan-2-yl]oxy-6-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2S,3R)-3-hydroxy-2-(tetradecanoylamino)octadecoxy]oxan-3-yl]oxy-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

2364.1206 Da
Monoisotopic Mass

-4.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2365.1279 451.3
[M+Na]+ 2387.1098 446.1
[M-H]- 2363.1133 467.9
[M+NH4]+ 2382.1544 449.7
[M+K]+ 2403.0838 440.0
[M+H-H2O]+ 2347.1179 436.7
[M+HCOO]- 2409.1188 445.8
[M+CH3COO]- 2423.1345 443.1
[M+Na-2H]- 2385.0953 481.2
[M]+ 2364.1201 413.6
[M]- 2364.1211 413.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.